HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (34) Citing Articles via Google Scholar Google Scholar Articles by Guo, X. Articles by Floros, J. Search for Related Content PubMed PubMed Citation Articles by Guo, X. Articles by Floros, J.

Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population

Depts of ¹ Cellular and Molecular Physiology, ⁵ Pediatrics, and ² Health Evaluation Sciences, The Pennsylvania State University College of Medicine,Hershey, PA, USA. ³ National institute of Respiratory Diseases. ⁴ Dept of Science National Autonymous University of Mexico, Mexico

CORRESPONDENCE: J. Floros, Dept of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, H166 Hershey, PA 17033, USA. Fax: 1 7175317667

Keywords: chronic obstructive pulmonary disease, gene interaction, surfactant protein, surfactant proteins A, B and D

Received: May 12, 2000
Accepted May 9, 2001

This work was supported by NIH R37 HL34788 and the General Clinical Research Center at the Pennsylvania State University College of Medicine.

Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation. It is most likely the result of complex interactions of environmental and genetic factors. Because pulmonary surfactant components play important roles in normal lung function, innate host defence, and inflammation in the lung, this study investigated the hypothesis that the surfactant protein genes are involved in certain cases of COPD.

Genotype analysis of surfactant protein (SP)-A, SP-B, SP-B-linked microsatellite, and SP-D marker alleles was performed in patients with COPD (n=97) and smoker (n=82) or nonsmoker (n=99) controls. Univariate and multiple logistic regression analyses were performed.

The regression analysis results between COPD and smokers revealed several COPD susceptibility alleles (AA62_A, B1580_C, D2S388_5), based on an odds ratio (OR >2.5). The predictive ability of this model for developing COPD is good (c=0.926). Allele-allele (B1580_C and D2S388_5) and allele-environment (i.e. smoking) interactions were detected. When smoker controls were compared to nonsmoker controls, marker D2S388_5 appeared to be smoking-independent (p=0.874), whereas marker alleles AA62_A (p=0.045) and B1580_5 (p=0.007) were smoking-dependent. Males were at higher risk (OR=6.05, p=0.001), and smoking (>50 packs·yr^–1) increased risk (OR=5.38, p=0.007). Males and alleles of loci flanking SP-B were associated with more severe cases (forced expiratory volume in one second/forced vital capacity 40%).

The present results indicate that the surfactant protein alleles may be useful in chronic obstructive pulmonary disease by either predicting the disease in a subgroup and/or by identifying disease subgroups that may be used for therapeutic intervention. These observations should now be confirmed in a larger study, designed according to strict epidemiological criteria.

This article has been cited by other articles:

				P. J. Castaldi, C. P. Hersh, J. J. Reilly, and E. K. Silverman Genetic Associations With Hypoxemia and Pulmonary Arterial Pressure in COPD Chest, March 1, 2009; 135(3): 737 - 744. [Abstract] [Full Text] [PDF]

				M. G. Foreman, D. L. DeMeo, C. P. Hersh, V. J. Carey, V. S. Fan, J. J. Reilly, S. D. Shapiro, and E. K. Silverman Polymorphic variation in surfactant protein B is associated with COPD exacerbations Eur. Respir. J., October 1, 2008; 32(4): 938 - 944. [Abstract] [Full Text] [PDF]

				C. P. Hersh, D. L. DeMeo, and E. K. Silverman National Emphysema Treatment Trial State of the Art: Genetics of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493. [Abstract] [Full Text] [PDF]

				J. M. Brehm and J. C. Celedon Chronic Obstructive Pulmonary Disease in Hispanics Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 473 - 478. [Abstract] [Full Text] [PDF]

				D. L. DeMeo, E. J. Campbell, A. F. Barker, M. L. Brantly, E. Eden, N. G. McElvaney, S. I. Rennard, R. A. Sandhaus, J. M. Stocks, J. K. Stoller, et al. IL10 Polymorphisms Are Associated with Airflow Obstruction in Severe {alpha}1-Antitrypsin Deficiency Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 114 - 120. [Abstract] [Full Text] [PDF]

				W. K. Steagall, J.-P. Lin, and J. Moss The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L448 - L453. [Abstract] [Full Text] [PDF]

				C. P. Hersh, D. T. Miller, D. J. Kwiatkowski, and E. K. Silverman Genetic determinants of C-reactive protein in COPD Eur. Respir. J., December 1, 2006; 28(6): 1156 - 1162. [Abstract] [Full Text] [PDF]

				P. M. Henson, R. W. Vandivier, and I. S. Douglas Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease? Proceedings of the ATS, November 1, 2006; 3(8): 713 - 717. [Abstract] [Full Text] [PDF]

				P. M. Henson, G. P. Cosgrove, and R. W. Vandivier State of the Art. Apoptosis and Cell Homeostasis in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, August 1, 2006; 3(6): 512 - 516. [Full Text] [PDF]

				E. K. Silverman Progress in chronic obstructive pulmonary disease genetics. Proceedings of the ATS, July 1, 2006; 3(5): 405 - 408. [Abstract] [Full Text] [PDF]

				C. P. Hersh, D. L. DeMeo, R. Lazarus, J. C. Celedon, B. A. Raby, J. O. Benditt, G. Criner, B. Make, F. J. Martinez, P. D. Scanlon, et al. Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 977 - 984. [Abstract] [Full Text] [PDF]

				W. E. Lawson and J. E. Loyd The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proceedings of the ATS, January 1, 2006; 3(4): 345 - 349. [Abstract] [Full Text] [PDF]

				R. P. Schleimer Innate Immune Responses and Chronic Obstructive Pulmonary Disease: "Terminator" or "Terminator 2"? Proceedings of the ATS, November 1, 2005; 2(4): 342 - 346. [Abstract] [Full Text] [PDF]

				J. Casey, J. Kaplan, E. N. Atochina-Vasserman, A. J. Gow, H. Kadire, Y. Tomer, J. H. Fisher, S. Hawgood, R. C. Savani, and M. F. Beers Alveolar Surfactant Protein D Content Modulates Bleomycin-induced Lung Injury Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 869 - 877. [Abstract] [Full Text] [PDF]

				S. Saxena, R. Kumar, T. Madan, V. Gupta, K. Muralidhar, and P. U. Sarma Association of Polymorphisms in Pulmonary Surfactant Protein A1 and A2 Genes With High-Altitude Pulmonary Edema Chest, September 1, 2005; 128(3): 1611 - 1619. [Abstract] [Full Text] [PDF]

				J. C. Grutters and R. M. du Bois Genetics of fibrosing lung diseases Eur. Respir. J., May 1, 2005; 25(5): 915 - 927. [Abstract] [Full Text] [PDF]

				R. Marttila, R. Haataja, S. Guttentag, and M. Hallman Surfactant Protein A and B Genetic Variants in Respiratory Distress Syndrome in Singletons and Twins Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1216 - 1222. [Abstract] [Full Text] [PDF]

				H Clark and K Reid The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema Arch. Dis. Child., November 1, 2003; 88(11): 981 - 984. [Abstract] [Full Text] [PDF]